Back
Chesapeake Energy 10K Form
Buy
68
CHK
Chesapeake Energy
Last Price:
90.27
Seasonality Move:
1.44%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2021-03-01 | 10K | CHK/Chesapeake Energy Annual |
2020-11-09 | 10Q | CHK/Chesapeake Energy Quarterly |
2020-08-10 | 10Q | CHK/Chesapeake Energy Quarterly |
2020-05-11 | 10Q | CHK/Chesapeake Energy Quarterly |
2020-04-29 | 10K | CHK/Chesapeake Energy Annual |
2020-02-27 | 10K | CHK/Chesapeake Energy Annual |
Receive CHK News And Ratings
See the #1 stock for the next 7 days that we like better than CHK
CHK Financial Statistics
Sales & Book Value
Annual Sales: | $11.44B |
---|---|
Cash Flow: | $-15M |
Price / Cash Flow: | 7.82 |
Annual Sales: | $78.35 |
Price / Book: | 1.15 |
Profitability
EPS (TTM): | 42.45000 |
---|---|
Net Income (TTM): | $6.24B |
Gross Margin: | $3.7B |
Return on Equity: | 74.4% |
Return on Assets: | 43.07% |
Chesapeake Energy Earnings Forecast
Key Chesapeake Energy Financial Ratios
- The Gross Profit Margin over the past 29 years for CHK is 32.33%.
- The Selling, General & Administrative Expenses for CHK have been equal to 1.24% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 3.30% of Operating Income.
- The Net Earning history of CHK is 43.14% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 15 years.
Chesapeake Energy Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Oil & Gas E&P |
Sector: | Energy |
Current Symbol: | CHK |
CUSIP: | 165167 |
Website: | chk.com |
Debt
Debt-to-Equity Ratio: | 0.2 |
---|---|
Current Ratio: | 1.34 |
Quick Ratio: | 0.95 |
Price-to-Earnings
Trailing P/E Ratio: | 2.71 |
---|---|
Forward P/E Ratio: | 14.34 |
CHK Technical Analysis vs Fundamental Analysis
Buy
68
Chesapeake Energy (CHK)
is a Buy
Is Chesapeake Energy a Buy or a Sell?
-
Chesapeake Energy stock is rated a Buy
The current Chesapeake Energy [CHK] share price is $90.26. The Score for CHK is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.